Developing new treatments for age-related osteoporosis.
Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.
This study is exploring new treatments for senile osteoporosis by looking at how certain proteins in bone cells respond to stress, with the goal of developing small drugs that can help strengthen bones and reduce fat in the bone marrow.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oak Ridge Therapeutic Discovery (Orrxd), LLC NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-10807685 on NIH RePORTER |
What this research studies
This research focuses on finding new ways to treat senile osteoporosis, a condition where bones weaken as people age. The approach involves understanding how certain proteins in bone cells act as sensors for mechanical stress, which is crucial for bone health. By using advanced drug design techniques, the researchers aim to create small molecules that can enhance bone formation and reduce fat accumulation in the bone marrow. These compounds have shown promise in laboratory tests by stimulating bone-building cells and inhibiting fat cell formation.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults experiencing symptoms of osteoporosis or those at risk of developing the condition.
Not a fit: Patients who are not experiencing age-related bone loss or those with other underlying conditions affecting bone health may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments that improve bone density and reduce the risk of fractures in older adults.
How similar studies have performed: Previous research has shown success in developing treatments targeting bone mechanosensing, indicating a promising avenue for this approach.
Where this research is happening
Memphis, United States
- Oak Ridge Therapeutic Discovery (Orrxd), LLC — Memphis, United States (Active)
Researchers
- Principal investigator: Quarles, L Darryl — Oak Ridge Therapeutic Discovery (Orrxd), LLC
- Study coordinator: Quarles, L Darryl
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.